190 related articles for article (PubMed ID: 20681651)
1. Glycyrrhizic acid and 18beta-glycyrrhetinic acid inhibit inflammation via PI3K/Akt/GSK3beta signaling and glucocorticoid receptor activation.
Kao TC; Shyu MH; Yen GC
J Agric Food Chem; 2010 Aug; 58(15):8623-9. PubMed ID: 20681651
[TBL] [Abstract][Full Text] [Related]
2. Glycyrrhizic acid and 18β-glycyrrhetinic acid recover glucocorticoid resistance via PI3K-induced AP1, CRE and NFAT activation.
Kao TC; Wu CH; Yen GC
Phytomedicine; 2013 Feb; 20(3-4):295-302. PubMed ID: 23218403
[TBL] [Abstract][Full Text] [Related]
3. Glycyrrhizic acid and 18β-glycyrrhetinic acid modulate lipopolysaccharide-induced inflammatory response by suppression of NF-κB through PI3K p110δ and p110γ inhibitions.
Wang CY; Kao TC; Lo WH; Yen GC
J Agric Food Chem; 2011 Jul; 59(14):7726-33. PubMed ID: 21644799
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of glycyrrhizic acid and 18beta-glycyrrhetinic acid in PC12 cells via modulation of the PI3K/Akt pathway.
Kao TC; Shyu MH; Yen GC
J Agric Food Chem; 2009 Jan; 57(2):754-61. PubMed ID: 19105645
[TBL] [Abstract][Full Text] [Related]
5. Anti-psoriasis effect of 18β-glycyrrhetinic acid by breaking CCL20/CCR6 axis through its vital active group targeting GUSB/ATF2 signaling.
Wei J; Zhang J; Hu F; Zhang W; Wu Y; Liu B; Lu Y; Li L; Han L; Lu C
Phytomedicine; 2024 Jun; 128():155524. PubMed ID: 38552435
[TBL] [Abstract][Full Text] [Related]
6. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M
BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482
[TBL] [Abstract][Full Text] [Related]
7. DGAEE, a newly synthesized derivative of glycyrrhetinic acid, potently attenuates mouse septic shock via its main metabolite DGA in an IL-10-dependent manner.
Luo J; Liu M; Wu X; Dou Y; Xia Y; Dai Y; Wei Z
Int Immunopharmacol; 2015 Dec; 29(2):583-590. PubMed ID: 26456500
[TBL] [Abstract][Full Text] [Related]
8. Nrf2-mediated liver protection by 18β-glycyrrhetinic acid against pyrrolizidine alkaloid-induced toxicity through PI3K/Akt/GSK3β pathway.
Wang Z; Ma J; He Y; Miu KK; Yao S; Tang C; Ye Y; Lin G
Phytomedicine; 2022 Jul; 102():154162. PubMed ID: 35598524
[TBL] [Abstract][Full Text] [Related]
9. Protective Effects of Glycyrrhizic Acid and 18β-Glycyrrhetinic Acid against Cisplatin-Induced Nephrotoxicity in BALB/c Mice.
Wu CH; Chen AZ; Yen GC
J Agric Food Chem; 2015 Feb; 63(4):1200-1209. PubMed ID: 25588318
[TBL] [Abstract][Full Text] [Related]
10. 18β-Glycyrrhetinic acid suppresses TNF-α induced matrix metalloproteinase-9 and vascular endothelial growth factor by suppressing the Akt-dependent NF-κB pathway.
Jayasooriya RG; Dilshara MG; Park SR; Choi YH; Hyun JW; Chang WY; Kim GY
Toxicol In Vitro; 2014 Aug; 28(5):751-8. PubMed ID: 24613819
[TBL] [Abstract][Full Text] [Related]
11. The selective effect of glycyrrhizin and glycyrrhetinic acid on topoisomerase IIα and apoptosis in combination with etoposide on triple negative breast cancer MDA-MB-231 cells.
Cai Y; Zhao B; Liang Q; Zhang Y; Cai J; Li G
Eur J Pharmacol; 2017 Aug; 809():87-97. PubMed ID: 28506909
[TBL] [Abstract][Full Text] [Related]
12. Glycyrrhetinic Acid Improves Insulin-Response Pathway by Regulating the Balance between the Ras/MAPK and PI3K/Akt Pathways.
Zhang Y; Yang S; Zhang M; Wang Z; He X; Hou Y; Bai G
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30871060
[TBL] [Abstract][Full Text] [Related]
13. 18β-Glycyrrhetinic acid monoglucuronide (GAMG) alleviates single-walled carbon nanotubes (SWCNT)-induced lung inflammation and fibrosis in mice through PI3K/AKT/NF-κB signaling pathway.
Zhang XL; Li B; Zhang X; Zhu J; Xie Y; Shen T; Tang W; Zhang J
Ecotoxicol Environ Saf; 2022 Sep; 242():113858. PubMed ID: 35809393
[TBL] [Abstract][Full Text] [Related]
14. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2.
Kratschmar DV; Vuorinen A; Da Cunha T; Wolber G; Classen-Houben D; Doblhoff O; Schuster D; Odermatt A
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):129-42. PubMed ID: 21236343
[TBL] [Abstract][Full Text] [Related]
15. Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3beta in endothelial cells.
Joshi MB; Ivanov D; Philippova M; Erne P; Resink TJ
FASEB J; 2007 Oct; 21(12):3083-95. PubMed ID: 17485554
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of selective in vitro and in silico BACE1 inhibitory potential of glycyrrhizin together with its metabolites, 18α- and 18β-glycyrrhetinic acid, isolated from Hizikia fusiformis.
Wagle A; Seong SH; Zhao BT; Woo MH; Jung HA; Choi JS
Arch Pharm Res; 2018 Apr; 41(4):409-418. PubMed ID: 29532412
[TBL] [Abstract][Full Text] [Related]
17. Novel 18β-glycyrrhetinic acid derivatives as a Two-in-One agent with potent antimicrobial and anti-inflammatory activity.
Tu B; Liang J; Ou Y; Zhang X; Zheng W; Wu R; Gan L; Li D; Lu Y; Wu J; David Hong W; Zhang K; Wu P; Jin J; Wong WL
Bioorg Chem; 2022 May; 122():105714. PubMed ID: 35276603
[TBL] [Abstract][Full Text] [Related]
18. A potential adjuvant chemotherapeutics, 18β-glycyrrhetinic acid, inhibits renal tubular epithelial cells apoptosis via enhancing BMP-7 epigenetically through targeting HDAC2.
Ma T; Huang C; Meng X; Li X; Zhang Y; Ji S; Li J; Ye M; Liang H
Sci Rep; 2016 May; 6():25396. PubMed ID: 27145860
[TBL] [Abstract][Full Text] [Related]
19. Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line.
Matsui S; Matsumoto H; Sonoda Y; Ando K; Aizu-Yokota E; Sato T; Kasahara T
Int Immunopharmacol; 2004 Dec; 4(13):1633-44. PubMed ID: 15454116
[TBL] [Abstract][Full Text] [Related]
20. Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner.
Eräsalo H; Hämäläinen M; Leppänen T; Mäki-Opas I; Laavola M; Haavikko R; Yli-Kauhaluoma J; Moilanen E
J Nat Prod; 2018 May; 81(5):1131-1142. PubMed ID: 29726680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
